U.S. markets closed
  • S&P 500

    3,585.62
    -54.85 (-1.51%)
     
  • Dow 30

    28,725.51
    -500.10 (-1.71%)
     
  • Nasdaq

    10,575.62
    -161.89 (-1.51%)
     
  • Russell 2000

    1,664.72
    -10.21 (-0.61%)
     
  • Crude Oil

    79.74
    -1.49 (-1.83%)
     
  • Gold

    1,668.30
    -0.30 (-0.02%)
     
  • Silver

    19.01
    +0.30 (+1.62%)
     
  • EUR/USD

    0.9801
    -0.0018 (-0.19%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • GBP/USD

    1.1166
    +0.0043 (+0.38%)
     
  • USD/JPY

    144.7290
    +0.2860 (+0.20%)
     
  • BTC-USD

    19,421.98
    -81.84 (-0.42%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Leviathan Completes Acquisition of Cannabis Retailer Tirthankar

·4 min read

Toronto, Ontario--(Newsfile Corp. - August 26, 2022) - Leviathan Natural Products Inc. (CSE: EPIC) (OTCQB: LVCNF) (FSE: IQ7) (the "Company" or "Leviathan") announces that further to the Company's press release dated October 25, 2021 (the "Initial News Release"), the Company has completed its acquisition (the "Acquisition") of all the issued and outstanding shares in Tirthankar Ltd. and related companies (the "Tirthankar").

Upon closing, the shareholders of the Tirthankar received cash consideration of $1.8 million and 15,750,000 common shares of the Company. Leviathan will also issue 250,000 common shares to certain employees of the Tirthankar as a retention bonus. For further information on the Acquisition, please refer to the Initial News Release.

About Leviathan Natural Products Inc.

Leviathan Natural Products Inc. is a multi-jurisdictional cannabis company, focused on becoming a leader in the Cannabis industry. The Company is focused on expanding its current operations through organic growth and by way of merger and acquisition transactions.

About Tirthankar Ltd.

Tirthankar Ltd. is a cannabis retail store operating with retail brands "T CANNABIS" and "COST CANNABIS" offering a wide variety of cannabis brands and products, including flower, pre-rolls, concentrates, edibles, beverages, vapes, topicals, seeds, and accessories.

Tirthankar has a strong presence in Ontario, operating fourteen (14) retail cannabis stores in Ontario, and has an additional three (3) more locations in development. Further, Cost Cannabis has two (2) locations in development in Saskatchewan, located in Regina and Saskatoon.

The retail cannabis stores operating through the T Cannabis and Cost Cannabis brands are expected to generate annual revenues of approximately $35 million in the first 12 months post the Acquisition.

The cannabis retail stores operating under the T Cannabis and Cost Cannabis brand are located in the following municipalities:

  • Acton, Ontario

  • Beamsville, Ontario

  • Cochrane, Ontario

  • Fort Frances, Ontario

  • Hearst, Ontario

  • Kenora, Ontario

  • Kirkland Lake, Ontario

  • Manitouwadge, Ontario

  • New Liskeard, Ontario

  • Peterborough, Ontario

  • Renfrew, Ontario

  • Rockland, Ontario

  • Scarborough, Ontario

  • Smiths Falls, Ontario

  • Sioux Lookout, Ontario

  • Tottenham, Ontario

  • Wawa, Ontario

  • Regina, Saskatchewan

  • Saskatoon, Saskatchewan

 

For more information, please contact:

Lucas Leone
Director
Leviathan Natural Products Inc.
Tel: (289) 228-6235
lucas@leviathan-naturals.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:

Certain information in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or negatives of these terms and similar expressions.

Forward-looking statements are based on certain assumptions, including successful application to be a licensed cannabis producer and seller, expected growth, results from operations, performance, industry trends and growth opportunities. While Leviathan considers these assumptions to be reasonable, based on information currently available, they are inherently subject to significant business, economic and competitive uncertainties and contingencies and they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking statements also necessarily involve known and unknown risks, including without limitation, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments, the inability to access sufficient capital on favorable terms, the medical and recreational cannabis industry in Canada in general, income tax and regulatory matters, the ability of Leviathan to execute its business strategies, competition, crop failure, currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ from those anticipated. Forward-looking statements are not guarantees of future performance. Except as required by law, Leviathan disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Source: Leviathan Natural Products Inc.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/135110